Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @MDe_Silva
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MDe_Silva
-
Prikvačeni tweet
https://www.youtube.com/watch?v=SJI4HaFkVzI&t=3s … If you're wondering what
@notablelabs is up to, this video is a great introduction into our current work in clinical trials.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you so much for the invitation to be on the
#Techtonics podcast David! Looking forward to your talk on Data Mining and Visualization at the#PMWC20 conference today.@VentureValkyrie Lisa it was a pleasure to meet you, I had a blast (especially with the band-kid jokes).https://twitter.com/DShaywitz/status/1219291929831256065 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to chatting with
@TinaMarrLarson and@ntilmans on this afternoon’s panel at 3 (registration link below). See everyone soon!#JPM2020https://twitter.com/notablelabs/status/1215034978397896704 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
Introducing Leaders in Tech: http://leadersintech.org . Learn more about our beginnings athttps://medium.com/@leadersintech/introducing-leaders-in-tech-58089a027f70 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for coming to the panel
@mackenzieboli I remind myself of this idea every day. It is easy to highlight challenges with precision medicine but if you take a step back the massive opportunity we have is to use these technologies to move beyond the era of one size fits all.https://twitter.com/mackenzieboli/status/1189296651871117312 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to log some miles (although I’m not exactly in shape these days haha) with
@notablelabs and@AlexsLemonade for pediatric cancer this September!https://www.alexslemonade.org/mypage/1799795/member/507673 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations on all the progress and thanks for hosting this morning
@ron_alfa and@RecursionPharma, it would be a blast to grow our long term friendship into a team effort against cancer. Looking forward to seeing you this afternoon@RecursionChris!https://twitter.com/ron_alfa/status/1152266019521454080 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Honored to be included with such an inspiring group of folks! Thank you
@svbizjournal, I’m looking forward to the event next week!https://twitter.com/svbizjournal/status/1151972162254884866 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Matthew De Silva proslijedio/la je Tweet
Emily Whitehead in Runners World! First CAR T patient treated for acute leukmia runs her first 5K!! https://www.runnersworld.com/runners-stories/a28102585/emily-whitehead-5k/ …pic.twitter.com/MBNVTMLNqH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
Our CTO Diane Heiser is about to give her talk on our immune oncology drug development platform at 10:50 in room 1 at
#CYTO2019@ISAC_CYTO. Come chat with us afterwords or at our happy hour tonight, 5:30 at the Vancouver Club (915 W. Hastings Street) https://bit.ly/31RHqiH pic.twitter.com/syiyx9gWj3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Antibody staining art from the booth at
#cyto2019#macsimaart @miltenyibiotecpic.twitter.com/QcdR1G8mQe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for hosting such an amazing conference
@zakkohane and@HarvardDBMI, just landed back in California and look forward to attending next year!https://twitter.com/zakkohane/status/1141060010983723008 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Empowered patients are the key to changing healthcare,
@MIT_CSAIL's Regina Barzilay's#breastcancer diagnosis refocused her#AI background into oncology because even the most basic questions "how have other patients who have disease similar to mine done?" are impossible#pm19hmspic.twitter.com/Cp8IH6n409
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This morning at
#pm19hms I heard someone ask a pharma person how they're using#AI, so wanted to highlight@AK_Chatterjee's@HarvardBiz article: pharma company used EHR data from a rare lymphoma to predict which patients would progress on 1st line therapy https://bit.ly/2AtTr2m pic.twitter.com/FRoH9v0545
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
Need a little Monday motivation? How about Dave Wottle in the 800 meters at 1972 Olympics. Put a good soundtrack behind this and I’ll run through a wallpic.twitter.com/aZT7F3nHsB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
5th Annual
#AI Precision Med Conference hosted by@HarvardMedicine/@HarvardDBMI just kicked off by@zakkohane, our founder and CEO@MDe_Silva will be on@DShaywitz's Hyperindividualized Treatments panel @ 2:30 w/@geochurch Ken Ehlert@UHC Timothy Yu@BostonChildrens#pm19hmspic.twitter.com/jpDLUPw6yZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
Dr. Aleshin's talk today highlighted the latest data from our
@StanfordMed clinical trial collaboration, especially which relapsed/refractory MDS patients are most likely to respond to venetoclax combinations (shown in these these box plots).#EHA24#EHA2019
pic.twitter.com/Uj3kbKzn7K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
Looking forward to seeing our data with Dr. Aleshin
@StanfordMed tomorrow at 11:45 in the Amtrium Room: Ex vivo drug sensitivity profiling in myelodysplastic syndrome (MDS) patients defines novel drug sensitivity patterns for predicting clinical therapeutic outcomes#EHA24#EHA19pic.twitter.com/mujXggV9BD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
THANK YOU to
@SlonePartners for putting together an engaging, diverse & on-point Biotech Career Panel for the 23rd#CCSF Biosymposium@UCSFOCPD May 17th w/ panelists from@CRiverLabs@notablelabs@Amgen@HelixRecruiting#SPEnvision@OfficialCCSF#biotech#womeninSTEMpic.twitter.com/S8eGXNAFLl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Matthew De Silva proslijedio/la je Tweet
Honored to participate in CCSF's 23rd Biosymposium May 17th, hosting the 2pm biotech career panel, "Starting a Career in Biotechnology & Life Sciences"
@UCSF@OfficialCCSF@CIRMnews@CalCommColleges@NSF@Genentech @SRiverLabs@NotableLabs@Amgen@HelixRecruiting#SPEnvisionpic.twitter.com/6uEdjxUcyW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.